# Grifols

the Triturus immunoassay analyzer automates ELISA-format testing, positioned within Grifols's broader blood-and-plasma diagnostics portfolio alongside its immunohematology sample-processing systems.


Source: https://en.bioecon.ru/companies/grifols/
Updated: 2026-08-15

- Country: Spain
- Ticker: NASDAQ:GRFS

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | EUR 7.52 billion in 2025 | https://www.grifols.com/documents/3625622/7320249/Grifols+IR+-+Q4+2024+Earnings+Presentation+ENG+260225.pdf/fe6a9486-ded9-fb21-587e-a1ebd18380e7?t=1740588633428, https://www.grifols.com/documents/3625622/8322595/pres-20260226-en.pdf/9871a296-dcbf-a2e8-98ac-f37a4d9400a0?t=1772121143218, https://www.grifols.com/documents/6155530/7244385/Press-Kit.pdf/f65e4dfd-dfac-4bd4-0799-c004b389fecb?t=1747060777964, https://www.grifols.com/en/view-news/-/news/grifols-reports-eur-4487-million-in-revenues-with-9-2-operating-growth-and-eur-597-million-in-net-profit |
| Headcount | more than 23,800 employees | https://www.albus-awards.com/en/about-grifols, https://www.grifols.com/documents/6155530/7244385/Press-Kit.pdf/f65e4dfd-dfac-4bd4-0799-c004b389fecb?t=1747060777964 |
| Production site | manufacturing locations in the U.S., Spain, and other international regions | https://www.grifols.com/documents/6155530/7244385/Press-Kit.pdf/f65e4dfd-dfac-4bd4-0799-c004b389fecb?t=1747060777964, https://www.grifols.com/en/view-news/-/news/grifols-reports-eur-4487-million-in-revenues-with-9-2-operating-growth-and-eur-597-million-in-net-profit, https://www.zh.grifolscn.com.cn/documents/3625622/7324255/Grifols+IR+-+2025+Capital+Markets+Day+270225_final.pdf/1edf0593-a2b0-8c57-e513-cad7b89645b0?t=1740676319523 |
| Capacity | 22 million liters/year fractionation capacity, aiming for 26 million liters/year by 2026 | https://www.grifols.com/documents/6155530/7244385/Press-Kit.pdf/f65e4dfd-dfac-4bd4-0799-c004b389fecb?t=1747060777964, https://www.grifols.com/en/view-news/-/news/grifols-reports-eur-4487-million-in-revenues-with-9-2-operating-growth-and-eur-597-million-in-net-profit |
| Regulatory approval | FDA-licensed facilities and products, including albumin and various diagnostic reagents and systems | https://www.grifols.com/documents/6155530/7244385/Press-Kit.pdf/f65e4dfd-dfac-4bd4-0799-c004b389fecb?t=1747060777964, https://www.grifols.com/en/view-news/-/news/grifols-reports-eur-4487-million-in-revenues-with-9-2-operating-growth-and-eur-597-million-in-net-profit |
| Certification | ISO 14001-certified environmental management system for main production facilities | https://www.grifols.com/documents/3625622/7320249/IAR_EN.pdf/51b647a9-78f6-961c-2681-9c3fcd21c0bc?t=1742200153753 |

Independent sources: albus-awards.com

## Technologies

- [Automated ELISA analyzers](https://en.bioecon.ru/technology/automated-elisa-analyzers/)